"People don't always appreciate this," says Rubino
Last reviewed: June 22, 2026 Last updated: June 22, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
While neither liraglutide nor semaglutide is FDA-approved for cardiovascular protection, research suggests both may help lower the risk of major heart-related events like heart attack, stroke, or cardiovascular death in people with type 2 diabetes
Reduced appetite (your brain thinks youve eaten enough)
With cash-pay prices starting at $149 a month 2 , we are breaking down barriers to clinically proven treatments and helping more people take control of their health
A combination of strength training, cardiovascular exercise, and mobility work often works well for many individuals